Autoregulatory and paracrine control of synaptic and behavioral plasticity by octopaminergic signaling.

Department of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Nature Neuroscience (Impact Factor: 14.98). 02/2011; 14(2):190-9. DOI: 10.1038/nn.2716
Source: PubMed

ABSTRACT Adrenergic signaling has important roles in synaptic plasticity and metaplasticity. However, the underlying mechanisms of these functions remain poorly understood. We investigated the role of octopamine, the invertebrate counterpart of adrenaline and noradrenaline, in synaptic and behavioral plasticity in Drosophila. We found that an increase in locomotor speed induced by food deprivation was accompanied by an activity- and octopamine-dependent extension of octopaminergic arbors and that the formation and maintenance of these arbors required electrical activity. Growth of octopaminergic arbors was controlled by a cAMP- and CREB-dependent positive-feedback mechanism that required Octβ2R octopamine autoreceptors. Notably, this autoregulation was necessary for the locomotor response. In addition, octopamine neurons regulated the expansion of excitatory glutamatergic neuromuscular arbors through Octβ2Rs on glutamatergic motor neurons. Our results provide a mechanism for global regulation of excitatory synapses, presumably to maintain synaptic and behavioral plasticity in a dynamic range.

Download full-text


Available from: Alex C Koon, Jul 07, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The octopamine and tyramine, as the invertebrate counterparts of the vertebrate adrenergic transmitters, control and modulate many physiological and behavioral processes. Both molecules mediate their effects by binding to specific receptors belonging to the superfamily of G-protein-coupled receptors. So far, four families of octopamine and tyramine receptors have been reported. Here, we described the functional characterization of one putative octopamine/tyramine receptor gene from the rice stem borer, Chilo suppressalis. By a mechanism of alternative splicing, this receptor gene (CsOA3) encodes two molecularly distinct transcripts, CsOA3S and CsOA3L. CsOA3L differs from CsOA3S on account of the presence of an additional 30 amino acids within the third intracellular loop. When heterologously expressed, both receptors cause increases of intracellular Ca(2+) concentration. The short form, CsOA3S, was activated by both octopamine and tyramine, resulting in decreased intracellular cAMP levels ([cAMP]i ) in a dose-dependent manner, whereas dopamine and serotonin are not effective. However, CsOA3L did not show any impact on [cAMP]i . Studies with series of agonists and antagonists confirmed that CsOA3 has a different pharmacological profile from that of other octopamine receptor families. The CsOA3 is, to our knowledge, a novel family of insect octopamine receptors. Octopamine, the invertebrate counterpart of noradrenaline, modulates many physiological processes. Four families of octopamine/tyramine receptors have been reported. We found that a novel family of octopamine receptors, which encodes two transcripts by alternative splicing, couple with different second messenger pathways. It implicated that one octopamine receptor gene could play different functional roles by alternative splicing.
    Journal of Neurochemistry 11/2013; 129(1). DOI:10.1111/jnc.12526 · 4.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Drosophila the monoamine octopamine, through mechanisms that are not completely resolved, regulates both aggression and mating behavior. Interestingly, our study demonstrates that the Drosophila obesity-linked homologues Transcription factor AP-2 (TfAP-2, TFAP2B in humans) and Tiwaz (Twz, KCTD15 in humans) interact to modify male behavior by controlling the expression of Tyramine β-hydroxylase (Tbh) and Vesicular monanime transporter (Vmat), genes necessary for octopamine production and secretion. Furthermore, we reveal that octopamine in turn regulates aggression through the Drosophila cholecystokinin (CCK) satiation hormone homologue Drosulfakinin (Dsk). Finally, we establish that TfAP-2 is expressed in octopaminergic neurons known to control aggressive behaviour and that TfAP-2 requires functional Twz for its activity. We conclude that genetically manipulating the obesity-linked homologues TfAP-2 and Twz is sufficient to affect octopamine signalling, which in turn modulates Drosophila male behavior through the regulation of the satiation hormone Dsk.
    Genetics 10/2013; 196(1). DOI:10.1534/genetics.113.158402 · 4.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The characteristic crawling behavior of Drosophila larvae consists of a series of rhythmic waves of peristalsis and episodes of head swinging and turning. The two biogenic amines octopamine and tyramine have recently been shown to modulate various parameters of locomotion, such as muscle contraction, the time spent in pausing or forward locomotion, and the initiation and maintenance of rhythmic motor patterns. By using mutants having altered octopamine and tyramine levels and by genetic interference with both systems we confirm that signaling of these two amines is necessary for larval locomotion. We show that a small set of about 40 octopaminergic/tyraminergic neurons within the ventral nerve cord is sufficient to trigger proper larval locomotion. Using single-cell clones, we describe the morphology of these neurons individually. Given various potential roles of octopamine and tyramine in the larval brain, such as locomotion, learning and memory, stress-induced behaviors or the regulation of the energy state, functions that are often not easy to discriminate, we dissect here for the first time a subset of this complex circuit that modulates specifically larval locomotion. Thus, these data will help to understand-for a given neuronal modulator-how specific behavioral functions are executed within distinct subcircuits of a complex neuronal network. J. Comp. Neurol. 520:3764-3785, 2012. © 2012 Wiley Periodicals, Inc.
    The Journal of Comparative Neurology 11/2012; 520(16):3764-85. DOI:10.1002/cne.23152 · 3.51 Impact Factor